Markets ultimately turned lower on Friday concluding what has been a hectic week for investors. ARK Funds followed suit but far outpaced the markets. ARKQ performed the best out of the group, down 0.4%, while ARKG did the worst, down 2.3% on the day. The gains from past year are slowly sliding away, but Cathie Wood may have something up her sleeve as she is constantly reshuffling her ETFs to stand up to market headwinds.
ARK Invest has been the talk of Wall Street over the past couple of years, outperforming the market and solidifying its place among the big players in the investments world. Wood is the founder and head of this investment house, and many have compared her rising star to the likes of Warren Buffett.
Many traders are looking to mirror the plays of famous investors and huge brokerage firms to capitalize on the gains that the big dogs are making. Lucky for us, ARK Invest releases a list of its trades at the end of each trading day.
While some companies would require a subscription service or monetary fee to see what makes ARK Invest tick, here at 24/7 Wall St. we would rather give you the data for free. Here is a quick look at some of the major purchases that ARK Invest executed on October 8, 2021. Also check out all the ARK Invest sales that took place that same day.
The ARK Fintech Innovation ETF (NYSEARCA: ARKF) deals mainly with up-and-coming fintech stocks, as the name suggests. Some of its biggest holdings include Square, Zillow, Pinterest, PayPal and Alibaba. Net assets for the fund are currently $4.0 billion. Here are a few notable purchases in this fund: NO BUYS
ARK Genomic Revolution ETF (NYSEARCA: ARKG) looks at companies across multiple industries, but the general focus is on health care and companies that are changing the game technologically in this field. The biggest holdings are Pacific Biosciences, Teladoc Health, CRISPR and Fate Therapeutics. Net assets for the fund are currently $9.7 billion. Here are some notable buys in this fund: 1,535,517 shares of Ginkgo Bioworks, 347,467 shares of Accolade, 136,060 shares of CRISPR, & 106,395 shares of Intellia.
ARK Innovation ETF (NYSEARCA: ARKK) has a particular focus on disruptive innovation across multiple industries, but primarily tech. Some of the biggest names are in this fund, including Tesla, Roku, Square, Zillow and Spotify. Net assets for this fund are currently $25.5 billion. Here are some notable purchases in this fund: 269,179 shares of Intellia, 268,472 shares of CRISPR, 129,130 shares of Beam Therapeutics, & 290,491 shares of Signify Health.
ARK Autonomous Technology & Robotics ETF (NYSEARCA: ARKQ) is focused, unsurprisingly, on companies that are in the field of autonomous technology and robotics, specifically ones that are disruptively innovating. Big names in this fund include Tesla, Alphabet, JD.com, Baidu and Iridium. Net assets for this fund are currently $3.1 billion. Here are a few buys of note in this fund: 294,655 shares of Archer Aviation, 40,310 shares of NIU Technologies, & 129,096 shares of Markforged.
ARK Next Generation Internet ETF (NYSEARCA: ARKW) is focused on companies that are disruptively innovating within the theme of the next generation of the internet. Some names in this fund are similar to the others, including Tesla, Square, Grayscale Bitcoin Trust, Facebook and Snap. Net assets for this fund are currently $6.4 billion. Here are a few notable purchases in this fund: NO BUYS.
Ark Space Exploration & Innovation ETF (NYSEARCA: ARKX) is focused primarily on companies developing technology around spaceflight. Big names in this fund include Trimble, Kratos, Nvidia, Amazon and Iridium. Net assets for this fund are currently $63.3 million. The one purchase worth noting in this fund: 37,823 shares of Archer Aviation.
Check out all the buys here:
| FUND | Direction | Ticker | Name | Shares |
|---|---|---|---|---|
| ARKG | Buy | DNA | GINKGO BIOWORKS HOLDINGS INC | 1,535,517 |
| ARKG | Buy | ACCD | ACCOLADE INC | 347,467 |
| ARKG | Buy | CRSP | CRISPR THERAPEUTICS AG | 136,060 |
| ARKG | Buy | NTLA | INTELLIA THERAPEUTICS INC | 106,395 |
| ARKG | Buy | BEAM | BEAM THERAPEUTICS INC | 37,753 |
| ARKG | Buy | TDOC | TELADOC HEALTH INC | 12,496 |
| ARKG | Buy | QSI | QUANTUM-SI INC | 112,210 |
| ARKG | Buy | SURF | SURFACE ONCOLOGY INC | 75,405 |
| ARKG | Buy | SLGC | SOMALOGIC INC | 21,202 |
| ARKG | Buy | DYNS | DYNAMICS SPECIAL PURPOSE CORP | 1,005 |
| ARKK | Buy | NTLA | INTELLIA THERAPEUTICS INC | 269,179 |
| ARKK | Buy | CRSP | CRISPR THERAPEUTICS AG | 268,472 |
| ARKK | Buy | BEAM | BEAM THERAPEUTICS INC | 129,130 |
| ARKK | Buy | TDOC | TELADOC HEALTH INC | 81,569 |
| ARKK | Buy | SGFY | SIGNIFY HEALTH INC | 290,491 |
| ARKK | Buy | TWOU | 2U INC | 49,563 |
| ARKK | Buy | SSYS | STRATASYS LTD | 616 |
| ARKQ | Buy | ACHR | ARCHER AVIATION INC | 294,655 |
| ARKQ | Buy | NIU | NIU TECHNOLOGIES | 40,310 |
| ARKQ | Buy | MKFG | MARKFORGED HOLDING CORP | 129,096 |
| ARKQ | Buy | VLD | VELO3D INC | 17,021 |
| ARKX | Buy | ACHR | ARCHER AVIATION INC | 37,823 |
| ARKX | Buy | PRNT | THE 3D PRINTING ETF | 5,678 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
Buffett Missed These Two…
Warren Buffett loves dividend stocks, and has stuffed Berkshire with some of his favorites.
But he overlooked two dividend legends that continue to print checks on a new level, they’re nowhere in his portfolio.
Unlock the two dividend legends Buffett missed in this new free report.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
